Anti-Citrullinated Peptide Antibodies Testing Rate over Time in Newly Diagnosed RA Patients - Data from Three Administrative Claims Databases (2007-2014)

被引：0
|
作者：
Alemao, E. [1 ]
Guo, Z. [1 ]
Burns, L. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
491
引用
收藏
页数：3
相关论文
共 2 条
  • [1] TESTING FOR ANTI-CITRULLINATED PEPTIDE ANTIBODIES IN US CLINICAL PRACTICE SETTINGS IN PATIENTS NEWLY DIAGNOSED WITH RA - DATA FROM THREE DATABASES BETWEEN 2007-2014
    Alemao, E.
    Guo, Z.
    Burns, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1020 - 1021
  • [2] Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: Data from the first Central-Eastern European cohort
    Besenyei, Timea
    Gyetvai, Agnes
    Szabo, Zoltan
    Fekete, Andrea
    Kapitany, Aniko
    Szodoray, Peter
    Laki, Judit
    Soos, Lilla
    Sipka, Sandor
    Szegedi, Gyula
    Lakos, Gabriella
    Szekanecz, Zoltan
    [J]. JOINT BONE SPINE, 2011, 78 (06) : 652 - 653
1